Nurix Therapeutics (NRIX) EPS (Basic) Growth (5y) (2024 - 2026)

Nurix Therapeutics (NRIX) EPS (Basic) Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Nurix Therapeutics 2.64 Bn 2.19 Bn -

Historic Data

Download Data
DateValue
May 31, 2026 -6.03%
Feb 28, 2026 -5.00%
Nov 30, 2025 6.63%
Aug 31, 2025 -11.72%
May 31, 2025 -17.66%
Feb 28, 2025 28.06%
Nov 30, 2024 26.60%
Aug 31, 2024 -0.33%